Lacuesta, Gina, and Jason K. Lee. 2022. “The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD”. Canadian Allergy & Immunology Today 2 (s11). Toronto, Canada:3–11. https://doi.org/10.58931/cait.2022.2s1148.